{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:17:51Z","timestamp":1787239071816,"version":"build-2736575974"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.phrs.2017.03.014","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T14:16:50Z","timestamp":1490019410000},"page":"97-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Gender differences in liver disease and the drug-dose gender gap"],"prefix":"10.1016","volume":"120","author":[{"given":"Elena","family":"Buzzetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pathik M.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Gerussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Tsochatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2017.03.014_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)00001-9","article-title":"Gender differences in pharmacological response","volume":"83","author":"Anderson","year":"2008","journal-title":"Int. Rev. Neurobiol."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1515\/cclm-2012-0849","article-title":"Gender medicine: a task for the third millennium","volume":"51","author":"Baggio","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"issue":"10","key":"10.1016\/j.phrs.2017.03.014_bib0015","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1210\/me.2009-0045","article-title":"DNA binding by estrogen receptor-alpha is essential for the transcriptional response to estrogen in the liver and the uterus","volume":"23","author":"Ahlbory-Dieker","year":"2009","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/mol.109.056705","article-title":"Sex differences in the expression of hepatic drug metabolizing enzymes","volume":"76","author":"Waxman","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2017.03.014_bib0025","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1177\/0960327113512860","article-title":"Female gender as a susceptibility factor for drug-induced liver injury","volume":"33","author":"Amacher","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/jwh.2005.14.19","article-title":"Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics","volume":"14","author":"Anderson","year":"2005","journal-title":"J. Womens Health (Larchmt)"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tips.2009.12.001","article-title":"Gender differences in drug toxicity","volume":"31","author":"Nicolson","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03602530903209288","article-title":"Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system","volume":"42","author":"Court","year":"2010","journal-title":"Drug Metab. Rev."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0045","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-2952(92)90010-G","article-title":"Effect of age and gender on the activity of human hepatic CYP3A","volume":"44","author":"Hunt","year":"1992","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.phrs.2017.03.014_bib0060","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.phrs.2017.03.014_bib0065","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.014_bib0070","doi-asserted-by":"crossref","first-page":"876","DOI":"10.5858\/arpa.2014-0214-RA","article-title":"Drug-induced liver injury","volume":"139","author":"Fisher","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.014_bib0075","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.phrs.2017.03.014_bib0080","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/liv.12958","article-title":"Chronic liver injury induced by drugs: a systematic review","volume":"35","author":"Stine","year":"2015","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0085","first-page":"113","article-title":"Drug-induced cholestasis","volume":"12","author":"Chitturi","year":"2001","journal-title":"Semin. Gastrointest. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0090","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2125.2000.00132.x","article-title":"Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine","volume":"49","author":"Fattinger","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0100","doi-asserted-by":"crossref","first-page":"e61186","DOI":"10.1371\/journal.pone.0061186","article-title":"Sex bias in experimental immune-mediated, drug-induced liver injury in BALB\/c mice: suggested roles for Tregs, estrogen, and IL-6","volume":"8","author":"Cho","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.toxlet.2011.03.031","article-title":"Estradiol and progesterone modulate halothane-induced liver injury in mice","volume":"204","author":"Toyoda","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: Interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J. Hepatol."},{"issue":"37","key":"10.1016\/j.phrs.2017.03.014_bib0115","doi-asserted-by":"crossref","first-page":"38563","DOI":"10.1074\/jbc.M405461200","article-title":"Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway","volume":"279","author":"Du","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.03.014_bib0120","series-title":"Textbook of Hepatology: From Basic Science to Clinical Practice","article-title":"Drug-Induced Liver Injury","author":"Pessayre","year":"2008"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0125","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0130","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0135","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.22177","article-title":"Acute liver failure: summary of a workshop","volume":"47","author":"Lee","year":"2008","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"10.1016\/j.phrs.2017.03.014_bib0140","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","article-title":"Trends in the management and burden of alcoholic liver disease","volume":"62","author":"Mathurin","year":"2015","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.phrs.2017.03.014_bib0145","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1360-0443.2009.02696.x","article-title":"Gender and alcohol consumption: patterns from the multinational GENACIS project","volume":"104","author":"Wilsnack","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.phrs.2017.03.014_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.08.023","article-title":"Sex and gender-related differences in alcohol use and its consequences: contemporary knowledge and future research considerations","volume":"156","author":"Erol","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.phrs.2017.03.014_bib0155","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3748\/wjg.v16.i11.1377","article-title":"Alcoholic liver injury: influence of gender and hormones","volume":"16","author":"Eagon","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/gut.41.6.845","article-title":"Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group","volume":"41","author":"Bellentani","year":"1997","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0175","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/hep.510230513","article-title":"Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study","volume":"23","author":"Becker","year":"1996","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0180","first-page":"731","article-title":"Pathogenesis of alcoholic liver disease \u2013 recent advances","volume":"26","author":"Nanji","year":"2002","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1465-3362.2009.00153.x","article-title":"Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis","volume":"29","author":"Rehm","year":"2010","journal-title":"Drug Alcohol Rev."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM199001113220205","article-title":"High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism","volume":"322","author":"Frezza","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"19\u201320","key":"10.1016\/j.phrs.2017.03.014_bib0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10354-006-0348-8","article-title":"Liver, alcohol and gender","volume":"156","author":"Muller","year":"2006","journal-title":"Wien. Med. Wochenschr."},{"issue":"4 Pt 1","key":"10.1016\/j.phrs.2017.03.014_bib0200","first-page":"G669","article-title":"Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin","volume":"274","author":"Ikejima","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0205","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0210","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0215","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0220","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0225","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0230","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","article-title":"Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis","volume":"26","author":"Toda","year":"1997","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0235","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0240","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.phrs.2017.03.014_bib0245","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1111\/j.1572-0241.2002.05921.x","article-title":"Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0250","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2007.08.013","article-title":"Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis","volume":"48","author":"Al-Chalabi","year":"2008","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.phrs.2017.03.014_bib0255","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2036.2006.03113.x","article-title":"Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis","volume":"24","author":"Miyake","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0260","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","article-title":"Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial","volume":"30","author":"Czaja","year":"1999","journal-title":"Hepatology"},{"issue":"6\u20137","key":"10.1016\/j.phrs.2017.03.014_bib0265","doi-asserted-by":"crossref","first-page":"A377","DOI":"10.1016\/j.autrev.2011.11.001","article-title":"The role of gender and organ specific autoimmunity","volume":"11","author":"Nussinovitch","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"10003","key":"10.1016\/j.phrs.2017.03.014_bib0270","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0275","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0280","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J. Hepatol."},{"issue":"11\u201312","key":"10.1016\/j.phrs.2017.03.014_bib0285","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/apt.12522","article-title":"Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study","volume":"38","author":"Papastergiou","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2017.03.014_bib0290","doi-asserted-by":"crossref","first-page":"610504","DOI":"10.1155\/2012\/610504","article-title":"Sex differences associated with primary biliary cirrhosis","volume":"2012","author":"Smyk","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0295","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0300","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bpg.2011.10.009","article-title":"Pathogenesis of primary sclerosing cholangitis","volume":"25","author":"Pollheimer","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0305","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0310","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0320","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl. 4","key":"10.1016\/j.phrs.2017.03.014_bib0325","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jvh.12475","article-title":"Historical epidemiology of hepatitis C virus (HCV) in select countries \u2013 volume 3","volume":"22","author":"Liakina","year":"2015","journal-title":"J. Viral Hepat."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0330","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/he.2000.5762","article-title":"Natural history of hepatitis C: its impact on clinical management","volume":"31","author":"Di Bisceglie","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"EASL Recommendations on Treatment of Hepatitis C 2016","volume":"66","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0340","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J. Viral Hepat."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0345","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jhep.2016.04.030","article-title":"Factors associated with spontaneous clearance of chronic hepatitis C virus infection","volume":"65","author":"Bulteel","year":"2016","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0350","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.phrs.2017.03.014_bib0355","doi-asserted-by":"crossref","first-page":"e27555","DOI":"10.1371\/journal.pone.0027555","article-title":"Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort","volume":"6","author":"van den Berg","year":"2011","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0360","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0365","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/humupd\/dmi008","article-title":"Sex hormones and the immune response in humans","volume":"11","author":"Bouman","year":"2005","journal-title":"Hum. Reprod. Update"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0370","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2006.09.011","article-title":"Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection","volume":"46","author":"Schott","year":"2007","journal-title":"J. Hepatol."},{"issue":"9055","key":"10.1016\/j.phrs.2017.03.014_bib0375","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.phrs.2017.03.014_bib0380","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1128\/JVI.00339-06","article-title":"Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism","volume":"80","author":"Paladino","year":"2006","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.phrs.2017.03.014_bib0385","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/jvh.12106","article-title":"Who is more likely to respond to dual treatment with pegylated-interferon and ribavirin for chronic hepatitis C? A gender-oriented analysis","volume":"20","author":"Di Marco","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0390","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1590\/S0037-86822010000300001","article-title":"Gender influence on treatment of chronic hepatitis C genotype 1","volume":"43","author":"Narciso-Schiavon","year":"2010","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0395","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cgh.2014.01.025","article-title":"The end of hepatitis C","volume":"12","author":"Sussman","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"20","key":"10.1016\/j.phrs.2017.03.014_bib0400","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1402454","article-title":"Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection","volume":"370","author":"Afdhal","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.phrs.2017.03.014_bib0405","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1056\/NEJMoa1402338","article-title":"ABT-450\/r-ombitasvir and dasabuvir with or without ribavirin for HCV","volume":"370","author":"Ferenci","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.phrs.2017.03.014_bib0410","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"issue":"8256","key":"10.1016\/j.phrs.2017.03.014_bib0415","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0420","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1440-1746.1993.tb01551.x","article-title":"Natural history of chronic hepatitis B virus infection: new light on an old story","volume":"8","author":"Chen","year":"1993","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"5 Suppl","key":"10.1016\/j.phrs.2017.03.014_bib0425","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1002\/hep.22929","article-title":"Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence","volume":"49","author":"Taylor","year":"2009","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.phrs.2017.03.014_bib0430","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/jmv.24243","article-title":"Gender differences in chronic HBsAg carriers in Italy: Evidence for the independent role of male sex in severity of liver disease","volume":"87","author":"Stroffolini","year":"2015","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0435","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.23163","article-title":"Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.phrs.2017.03.014_bib0440","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/jgh.12934","article-title":"Gender disparity in chronic hepatitis B: Mechanisms of sex hormones","volume":"30","author":"Wang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0445","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1053\/j.gastro.2011.12.045","article-title":"Estrogen receptor alpha represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4alpha","volume":"142","author":"Wang","year":"2012","journal-title":"Gastroenterology"},{"issue":"32","key":"10.1016\/j.phrs.2017.03.014_bib0450","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.3748\/wjg.v13.i32.4295","article-title":"Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection","volume":"13","author":"Shimizu","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0455","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/j.gastro.2015.06.045","article-title":"Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin","volume":"149","author":"Pietrangelo","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0460","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/shem.2002.35635","article-title":"Juvenile hemochromatosis","volume":"39","author":"Camaschella","year":"2002","journal-title":"Semin. Hematol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0465","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcmd.2003.08.003","article-title":"The ferroportin disease","volume":"32","author":"Pietrangelo","year":"2004","journal-title":"Blood Cells. Mol. Dis."},{"issue":"23","key":"10.1016\/j.phrs.2017.03.014_bib0470","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosis--a new look at an old disease","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0475","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2009.06.057","article-title":"Bone morphogenetic protein signaling is impaired in an HFE knockout mouse model of hemochromatosis","volume":"137","author":"Corradini","year":"2009","journal-title":"Gastroenterology"},{"issue":"9358","key":"10.1016\/j.phrs.2017.03.014_bib0480","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(03)12602-5","article-title":"Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis","volume":"361","author":"Bridle","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0485","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7326\/0003-4819-145-3-200608010-00009","article-title":"Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force","volume":"145","author":"Whitlock","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2017.03.014_bib0490","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ijlh.12347","article-title":"Epidemiology and diagnostic testing for hemochromatosis and iron overload","volume":"37","author":"Adams","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0495","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cld.2004.06.004","article-title":"Pathogenesis of hereditary hemochromatosis","volume":"8","author":"Fleming","year":"2004","journal-title":"Clin. Liver Dis."},{"issue":"8","key":"10.1016\/j.phrs.2017.03.014_bib0500","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4254\/wjh.v2.i8.302","article-title":"Gender-related variations in iron metabolism and liver diseases","volume":"2","author":"Harrison-Findik","year":"2010","journal-title":"World J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0505","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/00365520802273058","article-title":"Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications","volume":"44","author":"Tsochatzis","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.014_bib0510","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.phrs.2017.03.014_bib0515","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0520","first-page":"218","article-title":"Non-invasive assessment of liver fibrosis","volume":"25","author":"Papastergiou","year":"2012","journal-title":"Ann. Gastroenterol."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0525","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0530","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.20554","article-title":"Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease","volume":"41","author":"Weston","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0535","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.03.014_bib0540","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00535-010-0311-8","article-title":"Prevalence, gender, ethnic variations, and prognosis of NASH","volume":"46","author":"Hashimoto","year":"2011","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0545","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gut.2006.115345","article-title":"Menopausal status and hepatic steatosis in a general female population","volume":"56","author":"Volzke","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0550","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hep.24097","article-title":"Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease","volume":"53","author":"Ayonrinde","year":"2011","journal-title":"Hepatology"},{"issue":"7497","key":"10.1016\/j.phrs.2017.03.014_bib0555","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.38391.663287.E0","article-title":"Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial","volume":"330","author":"Bruno","year":"2005","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.phrs.2017.03.014_bib0560","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1001\/jama.1993.03500230084034","article-title":"Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys","volume":"269","author":"Johnson","year":"1993","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.phrs.2017.03.014_bib0565","doi-asserted-by":"crossref","first-page":"691","DOI":"10.4254\/wjh.v8.i16.691","article-title":"Redefining Budd-Chiari syndrome: a systematic review","volume":"8","author":"Shin","year":"2016","journal-title":"World J. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0570","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0575","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0016-5085(86)90855-3","article-title":"Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study","volume":"90","author":"Valla","year":"1986","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0580","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/jth.12529","article-title":"Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta-analysis","volume":"12","author":"Lapner","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2017.03.014_bib0585","doi-asserted-by":"crossref","first-page":"839875","DOI":"10.1155\/2015\/839875","article-title":"Prevalence of Budd-Chiari syndrome during pregnancy or puerperium: a systematic review and meta-analysis","volume":"2015","author":"Ren","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0590","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/gut.2008.167577","article-title":"Pregnancy: a risk factor for Budd-Chiari syndrome?","volume":"58","author":"Rautou","year":"2009","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0595","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000242420","article-title":"Adult Kasabach-Merritt syndrome due to hepatic giant hemangioma","volume":"3","author":"Aslan","year":"2009","journal-title":"Case Rep. Gastroenterol."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0600","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0028-1085099","article-title":"Hepatic vascular involvement related to pregnancy, oral contraceptives, and estrogen replacement therapy","volume":"28","author":"Perarnau","year":"2008","journal-title":"Semin. Liver Dis."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0605","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2016.04.001","article-title":"EASL Clinical Practice Guidelines on the management of benign liver tumours","volume":"65","author":"European Association for the Study of the Liver","year":"2016","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.phrs.2017.03.014_bib0610","first-page":"633","article-title":"Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes","volume":"9","author":"Guy","year":"2013","journal-title":"Gastroenterol. Hepatol. (N. Y.)"},{"issue":"7","key":"10.1016\/j.phrs.2017.03.014_bib0615","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jama.1979.03300070040020","article-title":"Epidemiology of hepatocellular adenoma. the role of oral contraceptive use","volume":"242","author":"Rooks","year":"1979","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0620","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1440-1673.1980.tb02201.x","article-title":"Oral contraceptive-induced hepatic adenoma and focal nodular hyperplasia","volume":"24","author":"Bryant","year":"1980","journal-title":"Australas. Radiol."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0625","first-page":"322","article-title":"Hepatic adenoma and oral contraceptive use","volume":"28","author":"Greer","year":"1989","journal-title":"J. Fam. Pract."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0630","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-2007-1007370","article-title":"Approach to a liver mass","volume":"13","author":"Reddy","year":"1993","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0635","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00004836-200109000-00015","article-title":"Rapid disappearance of hepatic adenoma after contraceptive withdrawal","volume":"33","author":"Aseni","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"issue":"19","key":"10.1016\/j.phrs.2017.03.014_bib0640","first-page":"224","article-title":"Hemorrhage caused by ruptured liver cell adenoma following long-term oral contraceptives: a case report","volume":"45","author":"Meissner","year":"1998","journal-title":"Hepatogastroenterology"},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0645","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7326\/0003-4819-86-2-180","article-title":"Regression of liver cell adenomas associated with oral contraceptives","volume":"86","author":"Edmondson","year":"1977","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0650","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2007.10.003","article-title":"Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma","volume":"48","author":"Rebouissou","year":"2008","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2017.03.014_bib0655","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1053\/j.gastro.2013.02.032","article-title":"Hepatocellular benign tumors-from molecular classification to personalized clinical care","volume":"144","author":"Nault","year":"2013","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.phrs.2017.03.014_bib0660","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.phrs.2017.03.014_bib0665","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1172\/JCI45967","article-title":"Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin\/T cell factor-dependent hepatocarcinogenesis","volume":"121","author":"Feng","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2017.03.014_bib0670","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cell.2011.11.026","article-title":"Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer","volume":"148","author":"Li","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0675","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/hep.25644","article-title":"Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis","volume":"56","author":"Ma","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0680","first-page":"790","article-title":"Elevated serum testosterone levels and risk of hepatocellular carcinoma","volume":"53","author":"Yu","year":"1993","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0685","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.2910630405","article-title":"A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China","volume":"63","author":"Yuan","year":"1995","journal-title":"Int. J. Cancer"},{"issue":"18","key":"10.1016\/j.phrs.2017.03.014_bib0690","first-page":"5106","article-title":"Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients","volume":"60","author":"Tanaka","year":"2000","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0695","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1530\/ERC-13-0283","article-title":"Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis","volume":"21","author":"Ma","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"23","key":"10.1016\/j.phrs.2017.03.014_bib0700","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1002\/cncr.28912","article-title":"Impact of sex on the survival of patients with hepatocellular carcinoma: a surveillance, epidemiology, and end results analysis","volume":"120","author":"Yang","year":"2014","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2017.03.014_bib0705","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/MEG.0b013e32831a86f8","article-title":"Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?","volume":"21","author":"Farinati","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.phrs.2017.03.014_bib0710","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/1097-0142(19930515)71:10<2941::AID-CNCR2820711009>3.0.CO;2-3","article-title":"Primary hepatocellular carcinoma in women of mainland China. A clinicopathologic analysis of 104 patients","volume":"71","author":"Cong","year":"1993","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.phrs.2017.03.014_bib0715","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3748\/wjg.v10.i11.1547","article-title":"Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma","volume":"10","author":"Tangkijvanich","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0720","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0166-3542(01)00185-1","article-title":"Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis","volume":"52","author":"Benvegnu","year":"2001","journal-title":"Antiviral Res."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0725","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.mcg.0000165670.25272.46","article-title":"Better survival in female patients with hepatocellular carcinoma: oral contraceptive pills related?","volume":"39","author":"Lam","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"issue":"8\u20139","key":"10.1016\/j.phrs.2017.03.014_bib0730","first-page":"505","article-title":"Gender difference in patients with hepatocellular carcinoma","volume":"91","author":"Hefaiedh","year":"2013","journal-title":"Tunis. Med."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0735","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/1097-0142(19950101)75:1<18::AID-CNCR2820750105>3.0.CO;2-#","article-title":"Better survival in female patients with hepatocellular carcinoma. Possible causes from a pathologic approach","volume":"75","author":"Ng","year":"1995","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0740","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.phrs.2017.03.014_bib0745","doi-asserted-by":"crossref","first-page":"e42875","DOI":"10.1371\/journal.pone.0042875","article-title":"Early Sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study","volume":"7","author":"Boudou-Rouquette","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0750","doi-asserted-by":"crossref","first-page":"e0153863","DOI":"10.1371\/journal.pone.0153863","article-title":"Cytochrome P450 1A2 metabolizes 17beta-estradiol to suppress hepatocellular carcinoma","volume":"11","author":"Ren","year":"2016","journal-title":"PLoS ONE"},{"issue":"32","key":"10.1016\/j.phrs.2017.03.014_bib0755","first-page":"446","article-title":"Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma","volume":"47","author":"Lee","year":"2000","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0760","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0168-8278(02)00413-0","article-title":"A comparison of fibrosis progression in chronic liver diseases","volume":"38","author":"Poynard","year":"2003","journal-title":"J. Hepatol."},{"issue":"37","key":"10.1016\/j.phrs.2017.03.014_bib0765","doi-asserted-by":"crossref","first-page":"13546","DOI":"10.3748\/wjg.v20.i37.13546","article-title":"Study of liver cirrhosis over ten consecutive years in Southern China","volume":"20","author":"Wang","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0770","doi-asserted-by":"crossref","first-page":"218","DOI":"10.47102\/annals-acadmedsg.V44N6p218","article-title":"Epidemiology and clinical evolution of liver cirrhosis in Singapore","volume":"44","author":"Chang","year":"2015","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.phrs.2017.03.014_bib0775","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med."},{"issue":"3","key":"10.1016\/j.phrs.2017.03.014_bib0780","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0785","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/jhep.2002.34734","article-title":"Burden of liver disease in the United States: summary of a workshop","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0790","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.ijir.3901316","article-title":"Assessment of sexual functions in patients with chronic liver disease","volume":"17","author":"Simsek","year":"2005","journal-title":"Int. J. Impot. Res."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.014_bib0795","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/BF03346632","article-title":"Male sexual disturbances in liver diseases: what do we know?","volume":"33","author":"Durazzo","year":"2010","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0800","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jgh.12695","article-title":"Testosterone in men with advanced liver disease: abnormalities and implications","volume":"30","author":"Sinclair","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0805","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/eje.1.01886","article-title":"Gonadal dysfunction in systemic diseases","volume":"152","author":"Karagiannis","year":"2005","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2017.03.014_bib0810","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.2012.04347.x","article-title":"Low testosterone levels as an independent predictor of mortality in men with chronic liver disease","volume":"77","author":"Grossmann","year":"2012","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"10","key":"10.1016\/j.phrs.2017.03.014_bib0815","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/apt.12974","article-title":"Review article: the management of cirrhosis in women","volume":"40","author":"Allen","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2017.03.014_bib0820","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/lt.21572","article-title":"Pregnancy and cirrhosis","volume":"14","author":"Tan","year":"2008","journal-title":"Liver Transpl."},{"issue":"25","key":"10.1016\/j.phrs.2017.03.014_bib0825","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.3748\/wjg.v20.i25.8061","article-title":"Clinical relevance of sarcopenia in patients with cirrhosis","volume":"20","author":"Montano-Loza","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0830","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nut.2014.07.005","article-title":"Sarcopenia impairs prognosis of patients with liver cirrhosis","volume":"31","author":"Hanai","year":"2015","journal-title":"Nutrition"},{"issue":"12","key":"10.1016\/j.phrs.2017.03.014_bib0835","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00198-003-1495-z","article-title":"The heterogeneity of bone disease in cirrhosis: a multivariate analysis","volume":"14","author":"Crawford","year":"2003","journal-title":"Osteoporos. Int."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2017.03.014_bib0840","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.50.suppl_1.i1","article-title":"Guidelines on the management of osteoporosis associated with chronic liver disease","volume":"50","author":"Collier","year":"2002","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phrs.2017.03.014_bib0845","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phrs.2017.03.014_bib0850","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/hep.22599","article-title":"Female sex and autoimmune hepatitis and the risk of portopulmonary hypertension","volume":"48","author":"Castano","year":"2008","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.phrs.2017.03.014_bib0855","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/MEG.0000000000000449","article-title":"Ten years of hospital admissions for liver cirrhosis in Portugal","volume":"27","author":"Silva","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2017.03.014_bib0860","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1432-2277.2012.01440.x","article-title":"Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients","volume":"25","author":"Giannelli","year":"2012","journal-title":"Transpl. Int."},{"key":"10.1016\/j.phrs.2017.03.014_bib0865","first-page":"29","article-title":"UNOS Liver Registry: ten year survivals","author":"Waki","year":"2006","journal-title":"Clin. Transpl."},{"issue":"7","key":"10.1016\/j.phrs.2017.03.014_bib0870","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1600-6143.2011.03498.x","article-title":"Sex-based disparities in liver transplant rates in the United States","volume":"11","author":"Mathur","year":"2011","journal-title":"Am. J. Transplant."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816307836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816307836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T14:23:18Z","timestamp":1658845398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816307836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":174,"alternative-id":["S1043661816307836"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.03.014","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gender differences in liver disease and the drug-dose gender gap","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}